Device Trial Radar · NCT03923387
Study to Evaluate the Safety and Effectiveness of MynxGrip Vascular Closure Device
Last checked: Nov 20, 2026Latest source record: Jul 29, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
306
Actual
Start
Apr 24, 2019
Primary completion
Oct 22, 2020
Study completion Oct 22, 2020
Sponsor
- Lead sponsor
- Cordis US Corp.Not on our public-company list
- Sponsor type
- Industry
- Collaborators
- Kun Tuo
- First posted
- Apr 22, 2019
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
To evaluate the safety and effectiveness of MynxGrip, in hemostasis of common femoral artery puncture site, compared with manual compression hemostasis in patients who have undergone diagnostic or interventional endovascular procedures utilizing a 5F, 6F or 7F procedural sheath.
Conditions
- Endovascular
Interventions
MynxGripDevice
Vascular Closure
Manual compressionOther
Manual compression is a commonly used method to achieve hemostasis of femoral artery
Primary outcomes
What the sponsor says the trial is designed to measure.
- Primary Effectiveness Endpoint: Time to HemostasisTime frame: Post procedure (time from the sheath removal to the time to achieving hemostasis)
- Primary Safety Endpoint: Major Complication RateTime frame: Through 30 days post procedure
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Beijing Tiantan Hospital Capitol Medical University
Beijing, China
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.